2021 | Therapeutic drug monitoring study on the switch from coformulated 600-mg efavirenz, tenofovir disoproxil fumarate, and emtricitabine to coformulated 400-mg efavirenz, tenofovir disoproxil fumarate, and lamivudine among HIV-positive patients with viral suppression | Huang, Wei-Chieh; Huang, Chun-Kai; Huang, Sung-Hsi; SHU-WEN LIN ; Ou, Shyh-Tyan; YI-TING CHEN ; Chen, Ya-Wen; Chang, Shu-Yuan; Liu, Wen-Chun; HSIN-YUN SUN ; CHIEN-CHING HUNG | Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi | 1 | 1 | |